Oncotelic Therapeutics Buy Hold or Sell Recommendation

OTLCDelisted Stock  USD 0.02  0  6.38%   
Given the investment horizon of 90 days and your way above-average risk tolerance, our recommendation regarding Oncotelic Therapeutics is 'Not Rated'. Macroaxis provides Oncotelic Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding OTLC positions.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
In addition, we conduct extensive research on individual companies such as Oncotelic and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Oncotelic Therapeutics. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Execute Oncotelic Therapeutics Buy or Sell Advice

The Oncotelic recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Oncotelic Therapeutics. Macroaxis does not own or have any residual interests in Oncotelic Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Oncotelic Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Oncotelic TherapeuticsBuy Oncotelic Therapeutics
Not Rated
For the selected time horizon Oncotelic Therapeutics has a Risk Adjusted Performance of (0), Jensen Alpha of (0.43), Total Risk Alpha of (2.41) and Treynor Ratio of (0.18)
We provide trade recommendations to complement the recent expert consensus on Oncotelic Therapeutics. Our dynamic recommendation engine exercises a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Oncotelic Therapeutics is not overpriced, please check all Oncotelic Therapeutics fundamentals, including its debt to equity, beta, and the relationship between the ebitda and short ratio . As Oncotelic Therapeutics appears to be a penny stock we also advise to check out its price to earning numbers.

Oncotelic Therapeutics Trading Alerts and Improvement Suggestions

Oncotelic Therapeutics is not yet fully synchronised with the market data
Oncotelic Therapeutics has some characteristics of a very speculative penny stock
Oncotelic Therapeutics has a very high chance of going through financial distress in the upcoming years
Oncotelic Therapeutics currently holds 9.8 M in liabilities with Debt to Equity (D/E) ratio of 0.4, which is about average as compared to similar companies. Oncotelic Therapeutics has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Oncotelic Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Oncotelic Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Oncotelic Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Oncotelic to invest in growth at high rates of return. When we think about Oncotelic Therapeutics' use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (9.39 M) with profit before overhead, payroll, taxes, and interest of 1.74 M.
Oncotelic Therapeutics currently holds about 399.77 K in cash with (4.43 M) of positive cash flow from operations.
Roughly 56.0% of Oncotelic Therapeutics outstanding shares are owned by corporate insiders
Latest headline from talkmarkets.com: Bull Of The Day Tactile Systems Technology

Oncotelic Therapeutics Returns Distribution Density

The distribution of Oncotelic Therapeutics' historical returns is an attempt to chart the uncertainty of Oncotelic Therapeutics' future price movements. The chart of the probability distribution of Oncotelic Therapeutics daily returns describes the distribution of returns around its average expected value. We use Oncotelic Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Oncotelic Therapeutics returns is essential to provide solid investment advice for Oncotelic Therapeutics.
Mean Return
-0.25
Value At Risk
-25
Potential Upside
25.00
Standard Deviation
14.27
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Oncotelic Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Oncotelic Therapeutics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Oncotelic . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Oncotelic Therapeutics Buy or Sell Advice

When is the right time to buy or sell Oncotelic Therapeutics? Buying financial instruments such as Oncotelic OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Oncotelic Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Recreation Thematic Idea Now

Recreation
Recreation Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Recreation theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Consideration for investing in Oncotelic OTC Stock

If you are still planning to invest in Oncotelic Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncotelic Therapeutics' history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk